Quest Diagnostics Q3 Adjusted Earnings, Revenue Rise; Raises 2026 Guidance

07:09 AM EDT, 10/22/2026 (MT Newswires) -- Quest Diagnostics (DGX) reported Q3 adjusted earnings Thursday of $3.00 per diluted share, up from $2.60 a year earlier. Analysts polled by FactSet expected $2.87. Revenue for the quarter ended Sept. 30 was $3.10 billion, up from $2.82 billion a year earlier. Analysts expected $3.05 billion. For 2026, the medical diagnostics company increased its adjusted EPS guidance to between $11.25 and $11.35, from $11.05 to $11.25, and its revenue guidance to between $12.07 billion and $12.11 billion, from $11.95 billion to $12.05 billion. Analysts expect $11.20 and $12.02 billion, respectively.